This classical mode of action as a nuclear receptor takes minutes to hours. "Estrogen also can change the firing activity of neurons in a matter of milliseconds, but it was not clear how this ...

Potential mechanisms of estrogen-driven carcinogenesis include prostatic estrogen receptor-mediated events, epigenetic changes, genotoxicity, hyperprolactinemia and chronic inflammation.

How estrogen's millisecond-fast action happens Date: October 2, 2024 Source: Baylor College of Medicine Summary: Researchers discovered a mechanism by which estrogen can trigger fast neuronal ...

OBJECTIVE: Estrogen has been implicated in feeding behavior and adiposity. This study was undertaken to elucidate the mechanism underlying the anti-obesity and anorectic action of estrogen and the ...

Mechanism of Action of Hormone Therapy In Atherosclerosis Revealed. by Angela Mohan on Sep 28 2020 11:45 AM. New study based on the early versus late intervention trial with estradiol data ...

Estrogen receptor-α (ERα) and its ligand estradiol (E2) has critical roles in breast cancer growth and are key therapeutic targets. In this study, we report a novel dual role of the adenosine A1 ...

By discovering the new mechanism by which estrogen suppresses lipid synthesis in the liver, endocrinologists have revealed a potential new approach toward treating certain liver diseases.

It is well known that estrogen is essential for healthy bone, and that when the production of estrogen is reduced, as occurs normally in postmenopausal women and pathogenically after exposure to ...

By discovering the new mechanism by which estrogen suppresses lipid synthesis in the liver, UC Irvine endocrinologists have revealed a potential new approach toward treating certain liver diseases.

Potential mechanisms of estrogen-driven carcinogenesis include prostatic estrogen receptor-mediated events, epigenetic changes, genotoxicity, hyperprolactinemia and chronic inflammation.

By discovering the new mechanism by which estrogen suppresses lipid synthesis in the liver, UC Irvine endocrinologists have revealed a potential new approach toward treating certain liver diseases.